Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

US Patent 11820982 · Granted Nov 21, 2023

Estimated economic value: $82,681,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) in2025
Treatment of sepsis with PCSK9 and LDLR modulators2025
Treatment of sepsis with PCSK9 and LDLR modulators2025
Materials and methods of treating MHC-I-opathy risk haplotypes2025
Materials and methods of treating MHC-I-opathy risk haplotypes2025
Materials and methods of treating MHC-I-opathy risk haplotypes2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing 2025
Genome-based methods for reducing cardiovascular risk2025
Genome-based methods for reducing cardiovascular risk2025
Kelch domain containing 7B (KLHDC7B) variants and uses thereof2025
Kelch domain containing 7B (KLHDC7B) variants and uses thereof2025